These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17127600)

  • 1. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM; Segura J
    Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project.
    Aspelund T; Thorgeirsson G; Sigurdsson G; Gudnason V
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):761-8. PubMed ID: 18043296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts.
    Giavarina D; Barzon E; Cigolini M; Mezzena G; Soffiati G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):311-8. PubMed ID: 17434054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T; Jackson RT; Wells S; Broad J; Bannink L
    N Z Med J; 2007 Mar; 120(1250):U2445. PubMed ID: 17339901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updating the assessment of cardiac risk: beyond Framingham.
    Borden WB; Davidson MH
    Rev Cardiovasc Med; 2009; 10(2):63-71. PubMed ID: 19593318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What impact will current trial data have on future guideline recommendations?
    Graham I
    Am J Med; 2005 Dec; 118 Suppl 12A():42-7. PubMed ID: 16356807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology.
    Graham IM; Stewart M; Hertog MG;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):839-45. PubMed ID: 17001227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCORE model in the POWER study: an attempt to focus the limited resources for prevention on patients with greatest need.
    De Backer G
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S19-24. PubMed ID: 18093410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids and CVD management: towards a global consensus.
    Ballantyne C; Arroll B; Shepherd J
    Eur Heart J; 2005 Nov; 26(21):2224-31. PubMed ID: 15972289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system.
    Horan PG; Kamaruddin MS; Moore MJ; McCarty D; Spence MS; McGlinchey PG; Murphy G; Jardine TC; Patterson CC; McKeown PP
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):521-5. PubMed ID: 17667642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.